RNA utilises many different mechanisms to control gene expression. Among the regulatory elements that respond to external stimuli, riboswitches are a prominent and elegant example. Riboswitches consist solely of RNA. They are characterised by binding of a small molecule ligand to the so-called aptamer domain, which results in a conformational change of the downstream expression platform that determines the output of the system. The modular organisation of riboswitches has resulted in the adoption of engineered riboswitches as artificial genetic control devices and a number of exciting proof-of-concept studies have been published. It should be noted thatthe majority of these studies were performed with the theophylline aptamer. Overall, there is no shortage of small molecule-binding aptamers. However, only a small fraction of them are suitable for RNA engineering since a classical SELEX protocol selects only for high-affinity binding but not for conformational switching. We now implemented RNA Capture-SELEX in our riboswitch developmental pipeline to integrate the required selection for high-affinity binding with the equally necessary RNA conformational switching. We consider this integrated approach a breakthrough in riboswitch development, as suitable sensor domains for RNA-based devices can now be developed quickly and easily against any ligand of choice.
Beatrix Suess is a Professor at the Technical University, Darmstadt. She received her PhD from the University of Erlangen, Germany where she was also a post-doctoral fellow. Suess was also a research fellow at the University of Vienna, Austria and at Yale University, USA. Dr. Suess’s research focuses on the ability of RNA to operate as a regulator of activities within the cell. In particular, her work focuses on the use of riboswitches as regulatory devices in synthetic biology applications.
For details of her research and recent publication, please visit HERE
© Copyright International BioDesign Research Conference - All rights reserved
